COMP <GO>
AORT vs UNH // GROSS PROFIT MARGIN
Artivion Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: AORT 3
— UNH 10
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $23.44 (+2.27%) • MKT CAP: $1.14B
gross-margins
64.40%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AORT VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AORT | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 64.40% | 88.57% | -24.17 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.50% | 11.47% | -6.97 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.3x | 16.4x | +2.85 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 0.07% | 6.48% | -6.41 | UNH | /fcf-yield <GO> |
| Operating Margin | 7.60% | 4.82% | +2.78 | AORT | /operating-margins <GO> |
| Net Profit Margin | 2.20% | 3.14% | -0.94 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.60% | 6.46% | +7.14 | AORT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.46 | 3.12 | -0.66 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | AORT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.6 | 59.2 | -12.62 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 98.3x | 17.1x | +81.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.14B | $368.83B | -$367.69B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AORT REV | UNH REV | AORT GROSS % | UNH GROSS % | AORT FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $441.3M | $447.57B | 64.4% | 88.7% | $839.0K | $16.07B |
| FY 2024 | $388.5M | $400.28B | 64.0% | 88.3% | $11.0M | $20.70B |
| FY 2023 | $354.0M | $371.62B | — | 89.6% | $18.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AORT // BETA —
UNH // BETA 0.33